HROW
Price
$27.67
Change
-$0.48 (-1.71%)
Updated
Oct 23, 11:11 AM (EDT)
Capitalization
1.06B
17 days until earnings call
Intraday BUY SELL Signals
SIGA
Price
$3.08
Change
-$0.07 (-2.22%)
Updated
Oct 23, 11:19 AM (EDT)
Capitalization
226.33M
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HROW vs SIGA

HROW vs SIGA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HROW vs. SIGA commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a Buy and SIGA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HROW with price predictions
Oct 22, 2026

HROW in +2.02% Uptrend, rising for three consecutive days on October 21, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HROW advanced for three days, in 240 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HROW's RSI Oscillator exited the oversold zone, 31 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for HROW just turned positive on October 20, 2026. Looking at past instances where HROW's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.

HROW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HROW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for HROW entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. HROW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (69.427) is normal, around the industry mean (10.407). P/E Ratio (-28.434) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.270) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (4.627) is also within normal values, averaging (178.797).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for SIGA with price predictions
Oct 22, 2026

SIGA sees MACD Histogram just turned negative

SIGA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 08, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 41 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SIGA as a result. In 74 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

SIGA moved below its 50-day moving average on October 19, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SIGA crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIGA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 57 cases where SIGA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

Following a +3.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where SIGA advanced for three days, in 234 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

SIGA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 140 of 174 cases where SIGA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.369) is normal, around the industry mean (10.407). P/E Ratio (-105.000) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.152). SIGA's Dividend Yield (0.762) is considerably higher than the industry average of (0.037). P/S Ratio (4.161) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. SIGA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
HROW vs SIGA: Fundamental Ratings
HROW
SIGA
OUTLOOK RATING
1..100
391
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
8174
P/E GROWTH RATING
1..100
14100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is significantly better than the same rating for HROW (84). This means that SIGA’s stock grew significantly faster than HROW’s over the last 12 months.

HROW's Profit vs Risk Rating (65) in the Pharmaceuticals Other industry is somewhat better than the same rating for SIGA (100). This means that HROW’s stock grew somewhat faster than SIGA’s over the last 12 months.

SIGA's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as HROW (99). This means that SIGA’s stock grew similarly to HROW’s over the last 12 months.

SIGA's Price Growth Rating (74) in the Pharmaceuticals Other industry is in the same range as HROW (81). This means that SIGA’s stock grew similarly to HROW’s over the last 12 months.

HROW's P/E Growth Rating (14) in the Pharmaceuticals Other industry is significantly better than the same rating for SIGA (100). This means that HROW’s stock grew significantly faster than SIGA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HROWSIGA
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
69%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (HROW: $28.15 vs. SIGA: $3.15)
Brand notoriety: HROW and SIGA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HROW: 70% vs. SIGA: 35%
Market capitalization -- HROW: $1.06B vs. SIGA: $226.33M
HROW [@Pharmaceuticals: Generic] is valued at $1.06B. SIGA’s [@Pharmaceuticals: Generic] market capitalization is $226.33M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 1 FA rating(s) are green while SIGA’s FA Score has 1 green FA rating(s).

  • HROW’s FA Score: 1 green, 4 red.
  • SIGA’s FA Score: 1 green, 4 red.
According to our system of comparison, HROW is a better buy in the long-term than SIGA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 5 TA indicator(s) are bullish while SIGA’s TA Score has 4 bullish TA indicator(s).

  • HROW’s TA Score: 5 bullish, 2 bearish.
  • SIGA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HROW is a better buy in the short-term than SIGA.

Price Growth

HROW (@Pharmaceuticals: Generic) experienced а -2.09% price change this week, while SIGA (@Pharmaceuticals: Generic) price change was -1.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.51%. For the same industry, the average monthly price growth was -10.60%, and the average quarterly price growth was +7.98%.

Reported Earning Dates

HROW is expected to report earnings on Nov 09, 2026.

SIGA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-2.51% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
HROW
Daily Signal:
Gain/Loss:
SIGA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AQST. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AQST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-0.32%
AQST - HROW
35%
Loosely correlated
+1.23%
AMRX - HROW
30%
Poorly correlated
+1.39%
AYTU - HROW
28%
Poorly correlated
+1.02%
RMTI - HROW
27%
Poorly correlated
-0.28%
TEVA - HROW
27%
Poorly correlated
-1.01%
More

SIGA and

Correlation & Price change

A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
+0.96%
EBS - SIGA
33%
Poorly correlated
+0.48%
ETON - SIGA
30%
Poorly correlated
+1.46%
AYTU - SIGA
28%
Poorly correlated
+1.02%
AMRX - SIGA
27%
Poorly correlated
+1.39%
SBFM - SIGA
25%
Poorly correlated
-22.47%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SHLD61.890.29
+0.47%
Global X Defense Tech ETF (SHLD)
TSEC25.220.09
+0.35%
Touchstone Securitized Income ETF (TSEC)
VMO8.77N/A
N/A
Invesco Municipal Opportunity Trust
FEBU30.31N/A
N/A
AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF (FEBU)
DUKQ31.34-0.30
-0.94%
Ocean Park Domestic ETF (DUKQ)